Dr. Guangyong Zou
As a biostatistician, I focus on developing and evaluating statistical methods that are useful for medical research, within the context of the following substantive areas:
- Cluster randomization trials;
- Patient reported outcomes;
- Inter-rater agreement/reliability;
- Health-related quality of life;
- Prospective epidemiological studies.
What is your current position?
A Professor focusing on statistical methods for correlated data. In addition, I am currently appointed as the Acting Chair for the department.
What is your Educational background?
- BSc Agronomy, Southwest University, China
- MSc Soil Science, McGill University, Canada
- MSc Statistics, University of Connecticut, USA
- PhD Plant Science, University of Connecticut, USA
- PhD Biostatistics, University of Western Ontario, Canada
Why did you choose to become a member of the Western University Faculty?
Schulich School of Medicine & Dentistry at Western makes my biostatistical research highly relevant to medical research. I get satisfaction from seeing my statistical methods being used to address important medical research questions.
Recent [selected] Publications:
- Zou GY (2012). Sample size formulas for estimating intraclass correlation coefficients with precision and assurance. Statistics in Medicine 31: 3972-3981.
- Zou GY, Donner A (2013). Extension of the modified Poisson regression model to prospective studies with correlated binary data. Statistical Methods in Medical Research22: 661-670.
- Zou GY, Yue L (2013). Using confidence intervals to compare several correlated areas under the receiver operating characteristic curves. Statistics in Medicine32: 5077-5090.
- Joy TR, Monjed A, Zou GY, Hegele RA, McDonald CG, Mahon JL (2014). Use of N-of-1 (single-patient) trials for statin-related myopathy. Annals of Internal Medicine160: 301-310.
- Khanna R, Zou GY, D'Haens G, Feagan BG, Sandborn WJ, Vandervoort MK, Rolleri RL, Bortey E, Paterson C, Forbes WP, Levesque BG (in press). A retrospective analysis: the development of patient reported outcome measures for the assessment of Crohn's disease activity. Alimentary Pharmacology Therapeutics.
Additional Projects:
- I am also a Senior Biostatistician at Robarts Clinical Trials Inc.
- Research Impact by Google Scholar